Publications

Therapeutic Areas

Centers of Excellence

Sort by

The economic and clinical burden of early versus late initiation of celecoxib among patients with osteoarthritis

Authors: A Shelbaya, C T Solem, C Walker, Y Wan, C Johnson, J C Cappelleri

Patient preferences for benefits, risks, and administration route of hypomethylating agents in myelodysplastic syndromes

Authors: A M Zeidan. J Tsai, M Karimi, J Schmier, S Jayade, E Zormpas, A Hassan, D Ruiters, C Anthony, K Hill, T Wert, M Botteman

Assessing the value of orphan drugs using conventional cost-effectiveness analysis: Is it fit for purpose?

Authors: M J Postma, D Noone, M H Rozenbaum, J A Carter, M F Botteman, E Fenwick & L P Garrison

Cost burden of endothelial keratoplasty in fuchs endothelial dystrophy: real-world analysis of a commercially insured US population (2014–2019)

Authors: D K Dhaliwal, V Chirikov, J Schmier, S Rege, S Newton

Effect of treating erectile dysfunction on management of systolic hypertension

Authors: R E Scranton, E Lawler, M Botteman, S Chittamooru, D Gagnon, R Lew, J Harnett, J M Gaziano

Influence of real-world characteristics on outcomes for patients with methicillin-resistant staphylococcal skin and soft tissue infections: A multi-country medical chart review in Europe

Authors: D Nathwani, C Eckmann, W Lawson, C T Solem, S Corman, J M Stephens, C Macahilig, D Simoneau, R Chambers, J Z Li & S Haider

Healthcare resource use and cost associated with timing of pharmacological treatment for major depressive disorder in the United States: a real-world study

Authors: M Mohty, W Knauf, D Romanus, S Corman, K Verleger, Y Kwon, D Cherepanov, M J Cambron-Mellott, H G Vikis, F Gonzalez, F Gavini, K Ramasamy

Real-world treatment patterns and outcomes in non-transplant newly diagnosed multiple Myeloma in France, Germany, Italy, and the United Kingdom

Authors: M Mohty, W Knauf, D Romanus, S Corman, K Verleger, Y Kwon, D Cherepanov, M J Cambron-Mellott, H G Vikis, F Gonzalez, F Gavini, K Ramasamy

Continuation of systemic treatments and outcomes for patients with chronic graft-versus-host disease in the USA

Authors: X Huang, N Joshi, L Luo, N Shamseddine, X Gao

Overall survival, costs and healthcare resource use by number of regimens received in elderly patients with newly diagnosed metastatic triple-negative breast cancer

Authors: A Aly, R Shah, K Hill, M F Botteman

View older